Editorial Type:
Article Category: Research Article
 | 
Online Publication Date: 09 Nov 2011

Yoga for Heart Failure Patients: A Feasibility Pilot Study with a Multiethnic Population

,
, and
Page Range: 77 – 83
DOI: 10.17761/ijyt.21.1.07m0081740027264
Save
Download PDF

Background: Congestive heart failure (CHF) is highly prevalent and the most costly cardiovascular illness in the United States. Yoga is known to be effective in lowering stress, lessening depression, and increasing physical fitness and may be used as an adjuvant management program for CHF patients. Primary Study Objective:To determine the feasibility of a yoga intervention program among a multiethnic CHF population living in underserved neighborhoods. Methods: Uncontrolled intervention trial. Setting: Kaiser Permanente Medical Centers,Richmond and Oakland, California. Participants: 14 CHF patients (7 female), mean age 64 (SD = 6.4) years, and 62% African-American. Intervention: Eight-week, 2x/week, 1-hr yoga classes that included meditation, breathing exercises, gentle yoga poses, and relaxation. Primary outcome measures: The intervention feasibility was measured by recruitment rates, participant retention and adherence. Body weight and self-reported depression and quality of life were measured before and after the intervention. Results: Among the 14 patients enrolled, 13 completed the intervention. Of those who completed the trial, 92% attended at least 50% of the classes. There was a significant reduction in weight (-3.5 lb, p = 0.01) and improvement in the severity of depression (p < 0.05), as well as a trend toward increased quality of life (p = 08). No adverse events were observed. Conclusions: This pilot trial demonstrates that it is feasible for patients with CHF to incorporate yoga into their lifestyle. Yoga may help with routine disease management, prevention of fluid retention, and improvement of depression and quality of life. A larger trial is needed to confirm efficacy and to determine the long-term effects on other important outcomes, such as hospital re-admission rates or prognostic biomarkers.

Smith ER. Heart failure--are we making progress? The Canadian Journal of Cardiology. 2002;18:1124-5.

Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010;121:e46-e215.

Wolinsky FD, Overhage JM, Stump TE, Lubitz RM, Smith DM. The risk of hospitalization for congestive heart failure among older adults. Medical Care. 1997;35:1031-43.

Wilson E. Congestive heart failure: a national priority. The Canadian Journal of Cardiology. 2001;17:1243-4.

Pelle AJ, Gidron YY, Szabo BM, Denollet J. Psychological predictors of prognosis in chronic heart failure. Journal of Cardiac Failure. 2008;14:341-50.

Grady KL, Dracup K, Kennedy G, Moser DK, Piano M, Stevenson LW, Young JB. Team management of patients with heart failure: a statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart Association. Circulation. 2000;102:2443-56.

Innes KE, Bourguignon C, Taylor AG. Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with yoga: a systematic review. Journal of the American Board of Family Practice. 2005;18:491-519.

Yang K. A review of yoga programs for four leading risk factors of chronic diseases. Evidence-Based Complementary and Alternative Medicine. 2007;4:487-91.

Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 2004;29:448-74.

Innes KE, Vincent HK, Taylor AG. Chronic stress and insulin resistance-related indices of cardiovascular disease risk, part 2: a potential role for mind-body therapies. Alternative Therapy in Health and Medicine. 2007;13:44-51.

Wood C. Mood change and perceptions of vitality: a comparison of the effects of relaxation, visualization and yoga. Journal of the Royal Society of Medicine. 1993;86:254-8.

Metra M, Felker GM, Zaca V, Bugatti S, Lombardi C, Bettari L, Voors AA, Gheorghiade M, Dei Cas L. Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. International Journal of Cardiology. 2010;144:175-9.

Hiatt RA, Friedman GD. The frequency of kidney and urinary tract diseases in a defined population. Kidney International. 1982;22:63-8.

Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. American Journal of Public Health. 1992;82:703-10.

Smith GR, Kramer TL, Hollenberg JA, Mosley CL, Ross RL, Burnam A. Validity of the Depression-Arkansas (D-ARK) Scale: a tool for measuring major depressive disorder. Mental Health Services Research. 2002;4:167-73.

Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. Journal American College of Cardiology. 2000;35:1245-55.

Howie-Esquivel J, Lee J, Collier G, Mehling W, Fleischmann K. Yoga in heart failure patients: a pilot study. Journal of Cardiac Failure. 2010;16:742-9.

Pullen PR, Thompson WR, Benardot D, Brandon LJ, Mehta PK, Rifai L, Vadnais DS, Parrott JM, Khan BV. Benefits of yoga for African American heart failure patients. Medicine and Science in Sports and Exercise. 2010;42:651-7.

Perlman LV, Ferguson S, Bergum K, Isenberg EL, Hammarsten JF. Precipitation of congestive heart failure: social and emotional factors. Annals of Internal Medicine. 1971;75:1-7.

Castellanos LR, Bhalla V, Isakson S, et al. B-type natriuretic peptide and impedance cardiography at the time of routine echocardiography predict subsequent heart failure events. Journal of Cardiac Failure. 2009;15:41-7.

  • Download PDF